Thoughts on PrEP – from the first person cured of HIV

by Timothy Ray Brown

Timothy Ray Brown was the first man cured of HIV. But he initially opted against the stem cell transplant that would later make history. photo: Positively Aware (PA)

Timothy Ray Brown was the first man cured of HIV. But he initially opted against the stem cell transplant that would later make history. photo: Positively Aware (PA)

When I first heard about the introduction of the use of Truvada for PrEP (pre-exposure prophylaxis) in 2012, I did not give it much thought. I had been cured of HIV in 2007, and had been told by my doctors that I am immune to the virus. Therefore, I did not think that PrEP was something I needed for myself. Since the whole reason for all of my work is to help the HIV-positive community and their loved ones by giving hope that HIV can be cured, I eventually decided that PrEP is an important tool in preventing new infections and this is an extremely large part of my mission. This article will explain why my mindset toward PrEP for sexually active individuals and injection drug users has been transformed dramatically.

continue reading / weiterlesen / ادامه مطلب

Vitamin D and HIV infection
نقش ویتامین دی و اچ آی وی

نقش مهمویتامین دی  برای بدن انسان. بویژه مبتلایان به اچ ای وی و بیماران ایدز

(for English text see below please!)

Vitamin-D-foodنور خورشید از جمله منبع اصلی تامین کننده ویتامین دی است و کمبود این ویتامین موجب شکل گیری امراضی از جمله دردهای استخوانی و عضلانی می‌شود

ویتامین «د» تنها نوع ویتامینی است که هورمون نیز محسوب می‌شود، این ویتامین برای محکم کردن استخوان‌ها و همچنین به حفظ قدرت عضلانی و جذب کلسیم بدن کمک می‌کند

براساس پژوهش‌های صورت گرفته، حدود 75 درصد از افراد مبتلا به ضعف عضلانی دچار کمبود ویتامین «د» هستند. همچنین تحقیقات نشان داده که کمبود ویتامین «د» خطر ابتلا به بیماری‌های قلبی و عروقی را دو برابر افزایش می‌دهد و اشخاصی که میزان دریافت ویتامین «د» در آنها ضعیف است بییشتر از دیگران در معرض ابتلا به بیماری دیابت، چاقی و بیماری‌های قلبی و عروقی قرار دارند

continue reading / weiterlesen / ادامه مطلب

AIDS rights group says criminal justice system has ‘HIV phobia’

A Winnipeg woman has been convicted of aggravated sexual assault for not telling her sex partner she is HIV-positive.

 photo: nicolasjoseschirado / Fotolia

photo: nicolasjoseschirado / Fotolia

A national AIDS rights group is upset by a Manitoba court case where an HIV-infected woman has been convicted of aggravated sexual assault.

continue reading / weiterlesen / ادامه مطلب

Schizophrenia and Psychosis
اسکیزوفرنی و جنون

Schizophrenia Information & Treatment Introduction

science photo library

science photo library

Throughout recorded history, the disorder we now know as schizophrenia has been a source of bewilderment. Those suffering from the illness once were thought to be possessed by demons and were feared, tormented, exiled or locked up forever.

In spite of advances in the understanding of its causes, course and treatment, schizophrenia continues to confound both health professionals and the public. It is easier for the average person to cope with the idea of cancer than it is to understand the odd behavior, hallucinations or strange ideas of the person with schizophrenia.

As with many mental disorders, the causes of schizophrenia are poorly understood. Friends and family commonly are shocked, afraid or angry when they learn of the diagnosis. People often imagine a person with schizophrenia as being more violent or out-of-control than a person who has another kind of serious mental illness. But these kinds of prejudices and misperceptions can be readily corrected.

continue reading / weiterlesen / ادامه مطلب

Ebola crisis: BBC revisits devastated village

A month ago BBC News visited the town of Kigbal in Sierra Leone to assess the devastation cause by the Ebola epidemic.

No help had reached the village. The dying and dead scattered the streets, and more several children had been orphaned.

Andrew Harding returned to the community to find out if any the passing weeks had brought any change.

Source: BBC

Ebola: basic fluid and nutrition care ‘being missed’

Ebola patients can lose five to 10 litres of fluid a day through vomiting and diarrhoea(photo: iStock)

Ebola patients can lose five to 10 litres of fluid a day through vomiting and diarrhoea (photo: iStock)

Ebola patients are missing out on basic care that could improve their chances of survival, according to a report in the Lancet medical journal.

Researchers say organisations are being misled by an “inaccurate view” that there is no proven treatment for Ebola.

They add that patients, who could be treated with fluids and electrolytes, are dying of dehydration.

Charities say there are many challenges to giving the intensive fluid replacement that some patients need.

continue reading / weiterlesen / ادامه مطلب

“Stigma Index” Empowers People With HIV to Make Stigma Visible, Confront Injustice

Laurel Sprague Offers Plain Talk on Stigma and Gives an Update on the First Year of the PLHIV Stigma Index in the U.S.

, November 26, 2014

Laurel Sprague

Laurel Sprague

HIV stigma is slippery. People can unknowingly play into HIV stigma, or not recognize the impact of stigma in their community. And stigma is enacted at all levels — by individuals, by communities, through public and private structures and in social and legal polities.

Given all this, how do we pin down, document and confront HIV stigma? Since 2008, the People Living with HIV (PLHIV) Stigma Index has measured and revealed the shape of stigma and discrimination experienced by people living with HIV. And the Stigma Index isn’t a study that delivers a report to sit on shelves. Planning and carrying out the index empowers people with HIV, and is itself a force of addressing HIV stigma.

continue reading / weiterlesen / ادامه مطلب

World AIDS Day 2014: Closing the gap in HIV prevention and treatment

1 December 2014
On World AIDS Day 2014, the World Health Organization will issue new recommendations to help countries close important gaps in HIV prevention and treatment services.

The guidelines will include advice on providing antiretroviral drugs for people who have been exposed to HIV – such as health workers, sex-workers, survivors of rape. They also include recommendations on preventing and managing common opportunistic infections and diseases such as severe bacterial and malaria infections, cryptococcal meningitis and the many oral and skin infections that can affect people living with HIV.

In 2013, WHO published consolidated guidelines on the use of antiretrovirals that promote earlier, simpler and less toxic interventions to keep people healthier for longer, and to help prevent HIV transmission. A growing number of countries with a high burden of HIV have adopted these guidelines. In 2013, a record 13 million people were able to access life-saving ARVs.

But too many people still lack access to comprehensive HIV treatment and prevention services. The 1 December supplement to the WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, released in June 2013, aims to help bridge that gap.

Source: WHO

Australia performs best in HIV treatment cascade – 62% with undetectable viral load
استرالیا بهترین عملکرد را در درمان اچ ای وی انجام میدهد

Alice Raymond, Imperial College London, speaking at HIV Glasgow. Image courtesy of HIV Drug Therapy Glasgow 2014 (

Alice Raymond, Imperial College London, speaking at HIV Glasgow. Image courtesy of HIV Drug Therapy Glasgow 2014 (

Australia and northern European countries are doing far better than North America at retaining people living with HIV in care and achieving viral suppression, according to a comprehensive survey of ‘treatment cascades’ in high-income countries presented on Tuesday at the HIV Drug Therapy Glasgow conference.

However, even in the best-performing countries viral suppression falls short of the aspirational target recently set by UNAIDS, and the survey identified country-specific weaknesses in performance. In the United Kingdom, diagnosis of HIV infection is the major weakness preventing higher rates of viral suppression in the population living with HIV, whereas linkage to care emerged as the primary weakness in the United States.

continue reading / weiterlesen / ادامه مطلب

NIH-Led Study Explores Prevention of Heart Disease in HIV-Infected People

Tuesday, Oct. 28, 2014

256px-World_Aids_Day_RibbonThe National Institutes of Health has launched a clinical trial to assess the effects of aspirin and cholesterol-lowering drugs, or statins, on preventing cardiovascular disease in people with long-term HIV infections. This group, which includes people on antiretroviral therapy (ART) as well as “elite controllers” who can limit the virus without ART, have a higher risk of developing heart disease and stroke compared to the general population. The study is funded by NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

“With the remarkable success of antiretroviral therapy, people living with HIV have a near-normal life expectancy,” said NIAID Director Anthony S. Fauci, M.D. “However, as this population ages, non-infectious complications such as cardiovascular disease begin to arise. We need to study the effects on the immune system of drugs normally prescribed for these conditions to ensure that they are beneficial for HIV-infected individuals.”

continue reading / weiterlesen / ادامه مطلب